Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin (2009)
- Authors:
- Autor USP: SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.ejphar.2009.02.015
- Subjects: ANGIOTENSINA II; SISTEMA CARDIOVASCULAR
- Language: Inglês
- Imprenta:
- Source:
- Título: European Journal of Pharmacology
- ISSN: 0014-2999
- Volume/Número/Paginação/Ano: v. 607, n. 1/3, p. 173-177, 2009
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
MONTENEGRO, Marcelo Freitas e PESSA, Lisandra R. e SANTOS, José Eduardo Tanus dos. Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin. European Journal of Pharmacology, v. 607, n. 1/3, p. 173-177, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2009.02.015. Acesso em: 15 out. 2024. -
APA
Montenegro, M. F., Pessa, L. R., & Santos, J. E. T. dos. (2009). Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin. European Journal of Pharmacology, 607( 1/3), 173-177. doi:10.1016/j.ejphar.2009.02.015 -
NLM
Montenegro MF, Pessa LR, Santos JET dos. Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin [Internet]. European Journal of Pharmacology. 2009 ; 607( 1/3): 173-177.[citado 2024 out. 15 ] Available from: https://doi.org/10.1016/j.ejphar.2009.02.015 -
Vancouver
Montenegro MF, Pessa LR, Santos JET dos. Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin [Internet]. European Journal of Pharmacology. 2009 ; 607( 1/3): 173-177.[citado 2024 out. 15 ] Available from: https://doi.org/10.1016/j.ejphar.2009.02.015 - Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6
- Sequence diversity and functional charactterization of the 5´-regulatory region of human cyp2c19
- Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction
- Nitrate decreases xanthine oxidoreductase-mediated nitrite reductase activity and attenuates vascular and blood pressure responses to nitrite
- eNOS gene polymorphirms may modify the effects produced by cardiovascular drugs on myocardial eNOS expression and activity [Carta]
- Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes
- Hemodynamic effects of bupropion in anesthetized dogs
- Hemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism
- Severity dependent increases in circulating cardiac troponin I and MMP-9 concentrations after experimental acute pulmonary thromboembolism
- Functional polymorphism located in MMP-9 gene promoter is strongly associated with obesity
Informações sobre o DOI: 10.1016/j.ejphar.2009.02.015 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
